{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:16:26Z","timestamp":1762917386311},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/nrl.0b013e318251eb23","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T06:39:53Z","timestamp":1335854393000},"page":"146-148","source":"Crossref","is-referenced-by-count":4,"title":["Improvement of Apathy After Levofloxacin Treatment"],"prefix":"10.1097","volume":"18","author":[{"given":"Melissa Jo","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan H.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Marras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-9-20210211","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1128\/AAC.47.10.3104-3108.2003","article-title":"Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy.","volume":"47","author":"Pea","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R3-9-20210211","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0378-4274(01)00509-4","article-title":"Clinical toxicological aspects of fluoroquinolones.","volume":"127","author":"Stahlmann","year":"2002","journal-title":"Toxicol Lett"},{"key":"R4-9-20210211","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF01987956","article-title":"Fluoroquinolones. Adverse reactions during clinical trials and postmarketing surveillance.","volume":"11","author":"Janknegt","year":"1989","journal-title":"Pharm Weekbl Sci"},{"key":"R6-9-20210211","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.brainresrev.2008.07.006","article-title":"The acute effects of NMDA antagonism: from the rodent to the human brain.","volume":"60","author":"Gunduz-Bruce","year":"2009","journal-title":"Brain Res Rev"},{"key":"R7-9-20210211","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1176\/jnp.8.3.341","article-title":"Neuropsychiatric side effects related to treatment with felbamate.","volume":"8","author":"McConnell","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"R8-9-20210211","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S1041610206003899","article-title":"Behavioral correlates of GABAergic disruption in Alzheimers disease.","volume":"19","author":"Lanctot","year":"2007","journal-title":"Int Psychogeriatr"},{"issue":"suppl 7","key":"R9-9-20210211","first-page":"vii54","article-title":"Apathy and the basal ganglia.","volume":"253","author":"Levy","year":"2006","journal-title":"J Neurol"},{"key":"R10-9-20210211","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases.","volume":"196","author":"Kim","year":"2009","journal-title":"Behav Brain Res"},{"key":"R11-9-20210211","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinsons disease.","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"R12-9-20210211","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.archger.2008.10.001","article-title":"Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimers disease (AD).","volume":"49","author":"Ricci","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"R13-9-20210211","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00019442-200303000-00012","article-title":"Executive dysfunction and apathy predict functional impairment in Alzheimer disease.","volume":"11","author":"Boyle","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"R14-9-20210211","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1161\/STROKEAHA.109.554410","article-title":"A longitudinal view of apathy and its impact after stroke.","volume":"40","author":"Mayo","year":"2009","journal-title":"Stroke"}],"container-title":["The Neurologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NRL.0b013e318251eb23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:41:15Z","timestamp":1620967275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00127893-201205000-00009"}},"subtitle":["An N-of-1 Study"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/nrl.0b013e318251eb23","relation":{},"ISSN":["1074-7931"],"issn-type":[{"value":"1074-7931","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}